|
|
||||||||
Department of Obstetrics and Gynecology, School of Medicine, University of Southern California, Los Angeles, California
Key Words. Angiotensin • Hematopoietic • In vitro • Myeloid • Erythroid
Kathleen E. Rodgers, Ph.D., Livingston Research Center, 1321 N. Mission Rd., Los Angeles, CA 90033, USA. Telephone: 323-227-4965; Fax: 323-222-7038; e-mail: krodgers{at}hsc.usc.edu
Angiotensin II (AII) induced the proliferation of hematopoietic progenitor cells (HPC) isolated from murine bone marrow or human cord blood. The formation of colonies with more than 50 cells increased approximately five-sevenfold in cultures of murine lineage-negative (Lin) bone marrow cells both in the presence (day 10) and absence (day 13) of colony-stimulating factors (CSF). This could be blocked with addition of Losartan, an antagonist of AIITR1. The increase in proliferation of early hematopoietic progenitors (LinSca l+ cells) by AII was approximately threefold and occurred only in the presence of CSF, suggesting that AII may affect mesenchymal stromal cells to induce CSF production and might directly affect early HPC. These in vitro studies were replicated with human HPC isolated from cord blood. AII also accelerated the proliferation and formation of colony-forming units (CFU)-granulocyte/erythroid/macrophage/megakaryocyte and CFU-granulocyte/macrophage colonies by CD34+CD38 enriched progenitors but only in the presence of CSF. Additional studies also indicated that AII can act to increase proliferation in suspension culture. Exposure of CD34+ cells to AII in suspension culture, prior to placement in a semisolid medium with erythropoietin, increased the formation of colonies with more than 50 cells and erythroid progenitors approximately five- and 20-fold, respectively. Further, mRNA for the AT1a receptor was expressed by human bone marrow CD34+CD38 cells, CD34+CD38 cells, and lymphocytes, but not mature myeloid cells. Similarly, mRNA for the AT1a receptor was expressed on human stromal cell clones, offering further support to the hypothesis that AII acts partially through the mesenchymal compartment of the bone marrow. These data suggest that AII may be a factor which stimulates the proliferation of hematopoietic progenitors.
This article has been cited by other articles:
![]() |
V. J. Jokubaitis, L. Sinka, R. Driessen, G. Whitty, D. N. Haylock, I. Bertoncello, I. Smith, B. Peault, M. Tavian, and P. J. Simmons Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues Blood, April 15, 2008; 111(8): 4055 - 4063. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yaren, I. Oztop, S. Turgut, G. Turgut, S. Degirmencioglu, and M. Demirpence Angiotensin-Converting Enzyme Gene Polymorphism Is Associated with Anemia in Non Small-Cell Lung Cancer Experimental Biology and Medicine, January 1, 2008; 233(1): 32 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fukuda, M. Sata, N. Ishizaka, and R. Nagai Critical Role of Bone Marrow Angiotensin II Type 1 Receptor in the Pathogenesis of Atherosclerosis in Apolipoprotein E Deficient Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 90 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Lepore, V. J. Jokubaitis, P. J. Simmons, K. N. Roeszler, R. Rossi, K. Bauer, and P. Q. Thomas A Role for Angiotensin-Converting Enzyme in the Characterization, Enrichment, and Proliferation Potential of Adult Murine Pituitary Colony-Forming Cells Stem Cells, November 1, 2006; 24(11): 2382 - 2390. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohtani, K. Egashira, Y. Ihara, K. Nakano, K. Funakoshi, G. Zhao, M. Sata, and K. Sunagawa Angiotensin II Type 1 Receptor Blockade Attenuates In-Stent Restenosis by Inhibiting Inflammation and Progenitor Cells Hypertension, October 1, 2006; 48(4): 664 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chon, M. C. Verhaar, H. A. Koomans, J. A. Joles, and B. Braam Role of Circulating Karyocytes in the Initiation and Progression of Atherosclerosis Hypertension, May 1, 2006; 47(5): 803 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Jankowski, R. Vanholder, M. van der Giet, L. Henning, M. Tolle, G. Schonfelder, A. Krakow, S. Karadogan, N. Gustavsson, J. Gobom, et al. Detection of Angiotensin II in Supernatants of Stimulated Mononuclear Leukocytes by Matrix-Assisted Laser Desorption Ionization Time-of-Flight/Time-of-Flight Mass Analysis Hypertension, September 1, 2005; 46(3): 591 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Savary, A. Michaud, J. Favier, E. Larger, P. Corvol, and J.-M. Gasc Role of the renin-angiotensin system in primitive erythropoiesis in the chick embryo Blood, January 1, 2005; 105(1): 103 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Charrier, A. Michaud, S. Badaoui, S. Giroux, E. Ezan, F. Sainteny, P. Corvol, and W. Vainchenker Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells Blood, August 15, 2004; 104(4): 978 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brunet de la Grange, Z. Ivanovic, V. Leprivey-Lorgeot, and V. Praloran Angiotensin II That Reduces the Colony-Forming Ability of Hematopoietic Progenitors in Serum Free Medium Has an Inverse Effect in Serum-Supplemented Medium Stem Cells, May 1, 2002; 20(3): 269 - 271. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
